XLUMENA INC. / BOSTON SCIENTIFIC CORPORATION / WESTERN TECHNOLOGY INVESTMENT / THIRD POINT VENTURES L.P. / PRISM VENTURE PARTNERS / CHARTER LIFE SCIENCES / ASCENT BIOMEDICAL VENTURES / APERTURE VENTURE PARTNERS LLC / Private / Acquisition / £42m

Financials

Transaction Value£42m

Consideration Type-

Capital Owned-

Capital Bid For100%

EV/Sales-

EV/EBITDA-

Share Price Premium-

One Off Charge-

Xlumena Inc.

Boston Scientific Corporation

Aperture Venture Partners

Ascent Biomedical Ventures

Charter Life Sciences

Prism Venture Partners

Third Point Ventures

Western Technology Investment

Sources